Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Julphar
Argus Health
Chinese Patent Office
UBS
Federal Trade Commission

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 6,818,613

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,818,613
Title: Aqueous sustained-release formulations of proteins
Abstract:The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
Inventor(s): Sharma; Basant (Bridgewater, NJ), Jin; Renzhe (Bridgewater, NJ), Rudolph; Sunitha (Doylestown, PA), Cheung; Wing K. (Warren, NJ), Begum; Selima (Edison, NJ), Kelley; Marian (Annandale, NJ)
Assignee: Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:10/037,369
Patent Claims:see list of patent claims

Details for Patent 6,818,613

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Sign Up Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ) 2036-04-30 RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 002 2001-09-17 ➤ Sign Up Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ) 2036-04-30 RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 003 2001-09-17 ➤ Sign Up Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ) 2036-04-30 RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 004 2001-09-17 ➤ Sign Up Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Teva
Fuji
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.